Skip to main content
. 2008 Aug 13;14(3):215–226. doi: 10.1111/j.1755-5949.2008.00048.x

Figure 2.

Figure 2

Mean human plasma concentrations of KNS‐760704 after single oral administration of a 50, 150, or 300 mg dose to adult volunteers under fasting conditions. Note semi‐logarithmic ordinate scale.

HHS Vulnerability Disclosure